{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T04:04:09Z","timestamp":1751342649904,"version":"3.41.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T00:00:00Z","timestamp":1730592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ijcha.2024.101551","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T20:57:24Z","timestamp":1731099444000},"page":"101551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Myocardial work assessment to improve baseline risk stratification in patients with transthyretin amyloidosis"],"prefix":"10.1016","volume":"55","author":[{"given":"Ana","family":"Moya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elayne","family":"Kelen de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Beles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitri","family":"Buytaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Goethals","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riet","family":"Dierckx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen","family":"Dauw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jozef","family":"Bartunek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ward A.","family":"Heggermont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Vanderheyden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ijcha.2024.101551_b0005","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jama.2024.0442","article-title":"Cardiac amyloidosis due to transthyretin protein: A review","volume":"331","author":"Ruberg","year":"2024","journal-title":"Jama"},{"issue":"9","key":"10.1016\/j.ijcha.2024.101551_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/CIRCHEARTFAILURE.119.006075","article-title":"Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis","volume":"12","author":"Maurer","year":"2019","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcha.2024.101551_b0015","first-page":"1","article-title":"Long-term tafamidis efficacy in patients with transthyretin amyloid cardiomyopathy by baseline left ventricular ejection fraction","author":"Drachman","year":"2024","journal-title":"Eur. J. Heart Fail."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101551_b0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/jamacardio.2023.4147","article-title":"Effect of tafamidis on cardiac function in patients with transthyretin amyloid cardiomyopathy","volume":"9","author":"Shah","year":"2023","journal-title":"Jama Cardiol."},{"key":"10.1016\/j.ijcha.2024.101551_b0025","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijcard.2019.12.063","article-title":"Diagnostic delay in wild type transthyretin cardiac amyloidosis \u2013 A clinical challenge","volume":"304","author":"Ladefoged","year":"2020","journal-title":"Int. J. Cardiol."},{"issue":"30","key":"10.1016\/j.ijcha.2024.101551_b0030","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/eurheartj\/ehx589","article-title":"A new staging systemfor cardiac transthyretin amyloidosis","volume":"39","author":"Gillmore","year":"2018","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.ijcha.2024.101551_b0035","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1002\/ehf2.12989","article-title":"Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage","volume":"7","author":"Law","year":"2020","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.ijcha.2024.101551_b0040","doi-asserted-by":"crossref","unstructured":"J. Saef et al., \u201cChanges in Left Ventricular Ejection Fraction and Clinical Trajectories of Transthyretin Cardiac Amyloidosis with Systolic Dysfunction,\u201d J. Clin. Med., vol. 12, no. 23, 2023, doi: 10.3390\/jcm12237250.","DOI":"10.3390\/jcm12237250"},{"key":"10.1016\/j.ijcha.2024.101551_b0045","doi-asserted-by":"crossref","DOI":"10.1002\/ehf2.15035","article-title":"Transthyretin cardiac amyloid: Broad heart failure phenotypic spectrum and implications for diagnosis","author":"Alonso","year":"2024","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.ijcha.2024.101551_b0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.amjcard.2023.06.022","article-title":"How Often Does Apical Sparing of Longitudinal Strain Indicate the Presence of Cardiac Amyloidosis?","volume":"202","author":"Wali","year":"2023","journal-title":"Am. J. Cardiology"},{"issue":"6","key":"10.1016\/j.ijcha.2024.101551_b0055","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/eurheartj\/ehs016","article-title":"A novel clinical method for quantification of regional left ventricular pressure-strain loop area: A non-invasive index of myocardial work","volume":"33","author":"Russell","year":"2012","journal-title":"Eur. Heart J."},{"issue":"June","key":"10.1016\/j.ijcha.2024.101551_b0060","first-page":"1","article-title":"Myocardial Work Assessment for the Prediction of Prognosis in Advanced Heart Failure","volume":"8","author":"Hedwig","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"10.1016\/j.ijcha.2024.101551_b0065","doi-asserted-by":"crossref","unstructured":"F. Loncaric et al., \u201cMyocardial work in hypertension and mitral regurgitation- insights from non-invasive assessment of left ventricular pressure-strain relations,\u201d Eur. Heart J. Cardiovasc Imaging, vol. 21, no. Supplement_1, 2020, doi: 10.1093\/ehjci\/jez319.033.","DOI":"10.1093\/ehjci\/jez319.033"},{"key":"10.1016\/j.ijcha.2024.101551_b0070","doi-asserted-by":"crossref","unstructured":"A. Moya et al., \u201cSerial Non-Invasive Myocardial Work Measurements for Patient Risk Stratification and Early Detection of Cancer Therapeutics-Related Cardiac Dysfunction in Breast Cancer Patients\u00a0: A Single-Centre Observational Study,\u201d J. Clinical Med. vol. 12, no. 1652, 2023, doi: 10.3390\/jcm12041652.","DOI":"10.3390\/jcm12041652"},{"issue":"24","key":"10.1016\/j.ijcha.2024.101551_b0075","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2024.101551_b0080","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/ehjci\/jex140","article-title":"Echocardiographic reference ranges for normal left ventricular 2D strain : results from the EACVI NORRE study","volume":"18","author":"Sugimoto","year":"2017","journal-title":"Eur. Heart J. Cardiovasc Imaging"},{"key":"10.1016\/j.ijcha.2024.101551_b0085","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.echo.2023.07.002","article-title":"State-of-the-art: noninvasive assessment of left ventricular function through myocardial work","volume":"vol. October, 36","author":"Moya","year":"2023","journal-title":"J Am Soc Echocardiogr"},{"issue":"2","key":"10.1016\/j.ijcha.2024.101551_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/openhrt-2020-001346","article-title":"Can myocardial work indices contribute to the exploration of patients with cardiac amyloidosis?","volume":"7","author":"Roger-Roll\u00e9","year":"2020","journal-title":"Open Heart"},{"issue":"2","key":"10.1016\/j.ijcha.2024.101551_b0095","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.echo.2022.08.015","article-title":"Left Ventricular Myocardial Work to Differentiate Cardiac Amyloidosis From Hypertrophic Cardiomyopathy","volume":"36","author":"Stassen","year":"2023","journal-title":"J. Am. Soc. Echocardiography"},{"key":"10.1016\/j.ijcha.2024.101551_b0100","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/echo.15681","article-title":"Strain-derived myocardial work in wild-type transthyretin cardiac amyloidosis with aortic stenosis \u2014 diagnosis and prognosis","volume":"40","author":"Ladefoged","year":"2023","journal-title":"Echocardiography"},{"issue":"6","key":"10.1016\/j.ijcha.2024.101551_b0105","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/ehjci\/jeaa097","article-title":"Prognostic implications of left ventricular myocardial work indices in cardiac amyloidosis","volume":"22","author":"Clemmensen","year":"2021","journal-title":"Eur. Heart J. Cardiovasc Imaging"},{"key":"10.1016\/j.ijcha.2024.101551_b0110","doi-asserted-by":"crossref","DOI":"10.1007\/s10554-024-03144-5","article-title":"Prognostic relevance of global work index and global constructive work in patients with non-ischemic dilated cardiomyopathy","author":"Chen","year":"2024","journal-title":"Int. J. Cardiovascular Imaging"}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906724002173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906724002173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T05:00:58Z","timestamp":1751259658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906724002173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":22,"alternative-id":["S2352906724002173"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2024.101551","relation":{},"ISSN":["2352-9067"],"issn-type":[{"type":"print","value":"2352-9067"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myocardial work assessment to improve baseline risk stratification in patients with transthyretin amyloidosis","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2024.101551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101551"}}